Partnerships
NuBioAge Taps 5W as Agency of Record to Promote Longevity Medicine and CALM 2027
By News Desk ·
Key takeaways
- 5W was named Agency of Record for nuBioAge, a physician-focused longevity medicine company founded by pharmacists Leonard Pastrana and Franck Kacou.
- 5W will lead national media relations, executive thought leadership and product seeding, and support publicity for CALM 2027 on February 19-20 in Fort Lauderdale.
- Ashley Barton, EVP at 5W, said longevity medicine is a rapidly growing space with opportunity to reach a broader audience.
5W has been named Agency of Record for nuBioAge, a physician-focused longevity medicine company, the public relations firm announced on November 11, 2026. PR Newswire carried the announcement. The partnership covers national media relations, executive thought leadership and publicity for the CALM 2027 conference in Fort Lauderdale, Florida.
What 5W Will Handle for NuBioAge
5W will run a strategic communications program that includes national media relations, executive thought leadership and targeted product seeding aimed at strengthening NuBioAge's position in clinical longevity medicine. The agency will also position co-founders Leonard Pastrana, PharmD, and Franck Kacou, PharmD, MBA, as expert voices on physician education, emerging therapies and personalized healthcare through media interviews, profiles and expert commentary.
NuBioAge, founded by pharmacists Pastrana and Kacou, brings together clinical experts, educational resources and industry partners to help medical professionals incorporate longevity medicine into their practices. Its professional education programs, multidisciplinary scientific team and network of companies offering diagnostics, technologies and clinical solutions give practitioners access to resources for the field.
5W will also support publicity for CALM 2027 (Clinical Application of Longevity Medicine), scheduled for February 19-20 in Fort Lauderdale. The annual conference gathers physicians, scientists and industry experts to explore practical applications of longevity medicine, with programming on peptide therapies, advanced diagnostics, artificial intelligence and strategies for building medical practices.
"Longevity medicine is an exciting and rapidly growing space, and there's so much opportunity to bring these conversations to a broader audience," said Ashley Barton, EVP, Consumer Lifestyle & Multicultural at 5W. Kacou said the partnership "will help amplify that mission, connect with more healthcare professionals, and bring greater visibility to the physicians and innovators shaping the future of longevity medicine."
NuBioAge's Clinical Network and Conference Record
According to akta.pro company records, NuBioAge was founded in 2018 and more than 2,000 practitioners are already using its Nucleus platform for longevity medicine education and clinical protocols. The same records show a May 2026 exclusive US clinical-channel partnership with Chrysea Labs to commercialize Sprevive, a high-purity spermidine complex, through registered practitioners and pharmacies. NuBioAge also scaled CALM into a recurring in-person education event in Fort Lauderdale and added the Clinical Longevity Summit topical series, with the next CALM confirmed for February 19-20, 2027.
CALM 2027 Dates in Fort Lauderdale
The conference is set for February 19-20, 2027, in Fort Lauderdale, Florida, according to the announcement. More information on the company is available at nubioage.com.